TransCode Therapeutics, Inc. Common Stock (RNAZ)

Typically moves ±12.34% on earnings
EARNINGS ANALYTICS
event_upcoming Est. Next Earnings: 2026-08-19 ESTIMATED
search

TransCode Therapeutics, Inc. Common Stock (RNAZ) has a 7-report earnings history dating back to Aug 23, 2021. Its average absolute post-earnings move is ±12.34%, and 57.1% of those reactions were positive. Its largest post-earnings gain was +6.21% (Nov 14, 2022) and its largest decline was -48.25% (Jan 16, 2024). The next earnings report is predicted for 2026-08-19 (estimated).

Earnings reactions

How RNAZ moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

7

Avg Abs. Movement

±12.34%

Positive %

57.1%

Negative %

42.9%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Apr 05, 2024 ☽ POST +1.23% open_in_new
Jan 16, 2024 ☽ POST -48.25% open_in_new
Nov 14, 2023 ☽ POST -10.29% open_in_new
Mar 31, 2023 ☽ POST -16.17% open_in_new
event

Earnings Count

7

Total earnings in dataset

trending_up

Avg Abs. Movement

±12.34%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 2 →
2
Funds holding
$474
Total value held
Buying
2 added · 0 reduced
Wells Fargo & Company/Mn
$474 NEW BUY
Royal Bank Of Canada
$0 NEW BUY

SEC Filing Types

Recent SEC Filings

10 most recent
Form Date Filed View on EDGAR
SCHEDULE 13D/A 20260723 open_in_new SEC.gov
424B3 20260720 open_in_new SEC.gov
424B3 20260720 open_in_new SEC.gov
8-K 20260720 open_in_new SEC.gov
8-K 20260717 open_in_new SEC.gov
DEFA14A 20260717 open_in_new SEC.gov
SCHEDULE 13D/A 20260717 open_in_new SEC.gov
8-K 20260702 open_in_new SEC.gov
8-K 20260618 open_in_new SEC.gov
8-K 20260603 open_in_new SEC.gov

Frequently asked about RNAZ earnings

When does TransCode Therapeutics, Inc. Common Stock report earnings next? expand_more

TransCode Therapeutics, Inc. Common Stock (RNAZ)'s next earnings date is estimated for 2026-08-19. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does RNAZ stock move after earnings? expand_more

Over 7 reports, RNAZ has moved an average of ±12.34% the session after earnings, closing higher 57.1% of the time.

What was RNAZ's biggest post-earnings move? expand_more

RNAZ's largest post-earnings gain on record was +6.21% on Nov 14, 2022, and its largest decline was -48.25% on Jan 16, 2024.

Where can I find TransCode Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of TransCode Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers